| Financial Year |
March 31 2022 |
| Monetary Funds |
155,413,065.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
200,775,821.27 |
| Accounts Receivable |
199,245,005.83 |
| Advances to Suppliers |
78,512,292.50 |
| Other Receivables |
525,754,296.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
215,726,928.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,000,000.00 |
| Other Current Assets |
15,956,750.76 |
| Total Current Assets |
1,504,715,215.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,307,696.08 |
| Investment Properties |
-- |
| Fixed Assetes |
493,591,863.08 |
| Under-construction Projects |
752,053.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,256,447.99 |
| R&D expenses |
-- |
| Goodwill |
220,139,223.77 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
108,754,208.54 |
| Other Non-Current Assets |
901,697.49 |
| Sub-Total of Non-Current Assets |
1,088,879,705.57 |
| Total Assets |
2,593,594,921.17 |
| Short-Term Loans |
981,138,739.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,319,207.98 |
| Accounts Payable |
89,667,054.87 |
| Accounts Received In Advance |
60,929,443.02 |
| Employee Compensation Payable |
6,066,661.50 |
| Taxes Payable |
59,565,566.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,033,166,079.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
220,539,919.27 |
| Other Current Liabilities |
5,094,332.56 |
| Sub-Total of Current Liabilities |
2,568,685,412.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
331,235,289.82 |
| Deferred Income Tax Liabilities |
5,967,641.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
366,721,962.84 |
| Total Liabilities |
2,935,407,375.37 |
| Paid-In Capital(Or Share Stock) |
1,005,743,085.00 |
| Capital Surplus |
-12,913,585.59 |
| Surplus Reserve |
52,139,727.59 |
| LESS:Treasury Stock |
13,429,099.37 |
| Undistributed Profits |
-1,560,661,481.38 |
| Minority Stockholder's Interest |
177,382,094.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-519,194,548.93 |
| Owner's Equity（Stockholder's Equity） |
-341,812,454.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,593,594,921.17 |
